A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised

EMBO Journal

Volumn 23, Issue 3, 2004, Pages 650-658

  Blom, Daniël ^a   Hirsch, Christian ^a   Stern, Patrick ^a   Tortorella, Domenico ^a   Ploegh, Hidde L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glycoprotein turnover; HCMV; Peptide: N glycanase; SiRNA; US2

Indexed keywords

GLUCAN SYNTHASE; GLYCOPROTEIN; GLYCOPROTEIN US2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PEPTIDE:N GLYCANASE; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

BETA 2-MICROGLOBULIN; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, SMALL INTERFERING; VIRAL ENVELOPE PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 1442313919     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600090     Document Type: Article

References (55)

1. Bebok Z, Mazzochi C, King SA, Hong JS, Sorscher EJ (1998) The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary. J Biol Chem 273: 29873-29878
2. Beckmann R, Spahn CM, Eswar N, Helmers J, Penczek PA, Sali A, Frank J, Blobel G (2001) Architecture of the protein-conducting channel associated with the translating 80S ribosome. Cell 107: 361-372
3. Bogyo M, McMaster JS, Gaczynska M, Tortorella D, Goldberg AL, Ploegh H (1997) Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc Natl Acad Sci USA 94: 6629-6634
4. Brodsky FM, Bodmer WF, Parham P (1979) Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol 9: 536-545
5. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247
6. Burda P, Aebi M (1999) The dolichol pathway of N-linked glycosylation. Biochim Biophys Acta 1426: 239-257
7. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison III CA, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154: 125-169
8. Ellgaard L, Helenius A (2001) ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 13: 431-437
9. Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4: 181-191
10. Fiebiger E, Story C, Ploegh HL, Tortorella D (2002) Visualization of the ER-to-cytosol dislocation reaction of a type 1 membrane protein. EMBO J 21: 1041-1053
11. Furman MH, Loureiro J, Ploegh HL, Tortorella D (2003) Ubiquitinylation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the ER. J Biol Chem 278: 34804-34811
12. Furman MH, Ploegh HL, Tortorella D (2002) Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J Biol Chem 277: 3258-3267
13. Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC (2001) Antigen presentation subverted: structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98: 6794-6799
14. Gewurz BE, Ploegh HL, Tortorella D (2002) US2, a human cytomegalovirus-encoded type 1 membrane protein, contains a noncleavable amino-terminal signal peptide. J Biol Chem 277: 11306-11313
15. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471
16. Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science 291: 2364-2369
17. Helenius J, Ng DT, Marolda CL, Walter P, Valvano MA, Aebi M (2002) Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein. Nature 415: 447-450
18. Hirsch C, Blom D, Ploegh HL (2003) A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J 22: 1036-1046
19. Hirsch C, Misaghi S, Blom D, Pacold ME, Ploegh HL (2004) Yeast N-glycanase distinguishes between native and non-native glycoproteins. EMBO Rep 5: 1-6
20. Huppa JB, Ploegh HL (1997) The a chain of the T cell receptor is degraded in the cytosol. Immunity 7: 113-122
21. Ishido S, Choi JK, Lee BS, Wang C, DeMaria M, Johnson RP, Cohen GB, Jung JU (2000) Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365-374
22. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69: 4830-4841
23. Kikkert M, Hassink G, Barel M, Hirsch C, van der Wal FJ, Wiertz E (2001) Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358: 369-377
24. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721
25. Lehrman MA (2001) Oligosaccharide-based information in endoplasmic reticulum quality control and other biological systems. J Biol Chem 276: 8623-8626
26. Lorenzo ME, Jung JU, Ploegh HL (2002) Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol 76: 5522-5531
27. Lybarger L, Wang X, Harris MR, Virgin HWt, Hansen TH (2003) Virus subversion of the MHC class I peptide-loading complex. Immunity 18: 121-130
28. Machold RP, Wiertz EJ, Jones TR, Ploegh HL (1997) The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med 185: 363-366
29. Menetret JF, Neuhof A, Morgan DG, Plath K, Radermacher M, Rapoport TA, Akey CW (2000) The structure of ribosome-channel complexes engaged in protein translocation. Mol Cell 6: 1219-1232
30. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P (2003) Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299: 1397-1400
31. Mosse CA, Meadows L, Luckey CJ, Kittlesen DJ, Huczko EL, Slingluff CL, Shabanowitz J, Hunt DF, Engelhard VH (1998) The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med 187: 37-48
32. Oda Y, Hosokawa N, Wada I, Nagata K (2003) EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299: 1394-1397
33. Parham P, Barnstable CJ, Bodmer WF (1979) Use of monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 123: 249-342
34. Park H, Suzuki T, Lennarz WJ (2001) Identification of proteins that interact with mammalian peptide: N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradation. Proc Natl Acad Sci USA 98: 11163-11168
35. Pilon M, Schekman R, Romisch K (1997) Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 16: 4540-4548
36. Plemper RK, Bohmler S, Bordallo J, Sommer T, Wolf DH (1997) Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 388: 891-895
37. Plemper RK, Egner R, Kuchler K, Wolf DH (1998) Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. J Biol Chem 273: 32848-32856
38. Rehm A, Engelsberg A, Tortorella D, Korner IJ, Lehmann I, Ploegh HL, Hopken UE (2002) Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. J Virol 76: 5043-5050
39. Rehm A, Stern P, Ploegh HL, Tortorella D (2001) Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor. EMBO J 20: 1573-1582
40. Schrag JD, Procopio DO, Cygler M, Thomas DY, Bergeron JJ (2003) Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci 28: 49-57
41. Shamu CE, Story CM, Rapoport TA, Ploegh HL (1999) The pathway of US11-dependent degradation of MHC Class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol 147: 45-58
42. Suzuki T, Kitajima K, Inoue Y, Inoue S (1995) Carbohydrate-binding property of peptide: N-glycanase from mouse fibroblast L-929 cells as evaluated by inhibition and binding experiments using various oligosaccharides. J Biol Chem 270: 15181-15186
43. Suzuki T, Park H, Hollingsworth NM, Sternglanz R, Lennarz WJ (2000) PNG1, a yeast gene encoding a highly conserved peptide: N-glycanase. J Cell Biol 149: 1039-1052
44. Suzuki T, Park H, Kwofie MA, Lennarz WJ (2001) Rad23 provides a link between the Png1 deglycosylating enzyme and the 26 S proteasome in yeast. J Biol Chem 276: 21601-21607
45. Suzuki T, Seko A, Kitajima K, Inoue Y, Inoue S (1994) Purification and enzymatic properties of peptide: N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation. J Biol Chem 269: 17611-17618
46. Takahashi N (1977) Demonstration of a new amidase acting on glycopeptides. Biochem Biophys Res Commun 76: 1194-1201
47. Tarentino AL, Plummer Jr TH (1994) Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol 230: 44-57
48. Tirosh B, Furman MH, Tortorella D, Ploegh HL (2002) Protein unfolding is not a prerequisite for ER-to-cytosol dislocation. J Biol Chem 12: 12
49. Tortorella D, Gewurz B, Schust D, Furman M, Ploegh H (2000) Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology. Immunol Invest 29: 97-100
50. Tortorella D, Story CM, Huppa JB, Wiertz EJ, Jones TR, Bacik I, Bennink JR, Yewdell JW, Ploegh HL (1998) Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol 142: 365-376
51. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996a) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779
52. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL (1996b) Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384: 432-438
53. Ye Y, Meyer HH, Rapoport TA (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652-656
54. Yoshida Y, Chiba T, Tokunaga F, Kawasaki H, Iwai K, Suzuki T, Ito Y, Matsuoka K, Yoshida M, Tanaka K, Tai T (2002) E3 ubiquitin ligase that recognizes sugar chains. Nature 418: 438-442
55. Yu H, Kaung G, Kobayashi S, Kopito RR (1997) Cytosolic degradation of T-cell receptor a chains by the proteasome. J Biol Chem 272: 20800-20804